TRK‐inhibitor control of an <i>NTRK</i>‐rearranged spindle cell tumor with malignant transformation in an adolescent-Reference-Cited by-同舟云学术

TRK‐inhibitor control of an NTRK‐rearranged spindle cell tumor with malignant transformation in an adolescent

Published:2023-05-02 Issue:9 Volume:70 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Higuchi Naoko¹,Honda Yuko¹,Koga Yuhki²,Asai Hiroshi¹²,Ono Hiroaki²,Kato Wakako¹²,Nakashima Kentaro¹²^ORCID,Cuesta Esther De La³,Tsujino Toshiaki⁴,Yamamoto Hidetaka⁵,Kusuhara Koichi¹,Hisaoka Masanori⁶,Ohga Shouichi²

Affiliation:

1. Department of Pediatrics, School of Medicine University of Occupational and Environmental Health Kitakyushu Japan

2. Department of Pediatrics, Graduate School of Medical Sciences Kyushu University Fukuoka Japan

3. Bayer HealthCare Pharmaceuticals, Inc. Whippany New Jersey USA

4. Bayer Yakuhin, Ltd. Osaka Japan

5. Department of Anatomic Pathology, Graduate of School of Medical Sciences Kyushu University Fukuoka Japan

6. Department of Pathology and Oncology, School of Medicine University of Occupational and Environmental Health Kitakyushu Japan

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.30379

Reference14 articles.

1. Unusual fibromatosis of the head and neck

2. Desmoid fibromatosis in children and adolescents: A conservative approach to management

3. Molecular Detection of the ETV6-NTRK3 Gene Fusion Differentiates Congenital Fibrosarcoma From Other Childhood Spindle Cell Tumors

4. The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives

5. Efficacy of Larotrectinib inTRKFusion–Positive Cancers in Adults and Children